중환자에서 스트레스성 궤양 예방 약물에 따른 감염성 합병증 발생률 비교

키워드

참고문헌 (30)

1. Ali T, "Stress-induced ulcer bleeding in critically ill patients", Gastroenterol Clin North Am, 38(2), pp.245~265 (2009)
2. Krag M, "Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review", Acta Anaesthesiol Scand, 57(7), pp.835~847 (2013)
3. Cook DJ, "Stress ulcer prophylaxis in the critically ill: a meta-analysis", Am J Med, 91(5), pp.519~527 (1991)
4. Cook DJ, "Canadian Critical Care Trials Group. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients", Crit Care, 5(6), pp.368~375 (2001)
5. Fennerty MB, "Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression", Crit Care Med, 30(6 Suppl), pp.S351~S355 (2002)
6. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis, "ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998", Am J Health Syst Pharm, 56(4), pp.347~379 (1999)
7. Netzer P, "Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours", Am J Gastroenterol, 94(2), pp.351~357 (1999)
8. Levy MJ, "Comparison of omeprazole and ranitidine for stress ulcer prophylaxis", Dig Dis Sci, 42(6), pp.1255~1259 (1997)
9. Beaulieu M, "Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit?", J Critical Care, 23, pp.513~518 (2008)
10. Howell MD, "Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection", Arch Intern Med, 170(9), pp.784~790 (2010)
11. Barletta JF, "Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients", Crit Care, 18(6), pp.714~ (2014)
12. Buendgens L, "Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea", J Critical Care, pp.696.e11~696.e15 (2014)
13. Herzig SJ, "Acid-suppressive medication use and the risk for hospital-acquired pneumonia", JAMA, 301(20), pp.2120~2128 (2009)
14. Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies: development and validation", J Chronic Dis, 40(5), pp.373~383 (1987)
15. Kastner C, "The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting", Prostate Cancer Prostatic Dis, 9(3), pp.270~274 (2006)
16. MacLaren R, "Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit", JAMA Intern Med, 174(4), pp.564~574 (2014)
17. Cook D, "A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group", N Engl J Med, 338(12), pp.791~797 (1998)
18. Kantorova I, "Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial", Hepatogastroenterology, 51(57), pp.757~761 (2004)
19. Daley RJ, "Prevention of stress ulceration:current trends in critical care", Crit Care Med, 32(10), pp.2008~2013 (2004)
20. Miano TA, "Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients", Chest, 136(2), pp.440~447 (2009)
21. Herzig SJ, "Acid-suppressive medication use in acute stroke and hospital-acqiored pneumonia", Ann Neurol, 76, pp.712~718 (2014)
22. Bateman BT, "Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients:cohort study", BMJ, 347, pp.f5416~ (2013)
23. Herzig SJ, "Risk factors for nosocomial gastrointestinal bleeding and use of acid-suppressive medication in non-critically ill patients", J Gen Intern Med, 28(5), pp.683~690 (2013)
24. Fohl AL, "Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?", World J Gastrointest Pharmacol Ther, 2(3), pp.17~26 (2011)
25. Eom CS, "Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis", CMAJ, 183(3), pp.310~319 (2011)
26. Laheij RJ, "Risk of communityacquired pneumonia and use of gastric acid-suppressive drugs", JAMA, 292(16), pp.1955~1960 (2004)
27. Sarkar M, "Proton-pump inhibitor use and the risk for community-acquired pneumonia", Ann Intern Med, 149(6), pp.391~398 (2008)
28. Lin PC, "The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis", Crit Care Med, 38(4), pp.1197~1205 (2010)
29. Barkun AN, "Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis", Am J Gastroenterol, 107(4), pp.507~520 (2012)
30. Alhazzani W, "Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis", Crit Care Med, 41(3), pp.693~705 (2013)

관련 논문AI추천